Set of genes predicts severity of dengue, study reports

Set Of Genes Predicts Severity Of Dengue, Study Reports blogpost is one based on the Health and Medical Updates class, posted on top of our publisher Linda Norton with January 29, 2019, those paper might want to search upon that hastag dengue, genes, predicts, reports, Set, severity, Study. I'm joyful to pleased you together with providing those other paper from health together with I am always publishing the paragraph daily.


Credit: CC0 Public Domain

There’s no such thing as a “good” case of dengue fever, but some are worse than others, and it’s difficult to determine which patients will make a smooth recovery and which may find their condition life-threatening.

Now, after scouring the gene expression of hundreds of patients infected with dengue virus—a mosquito-borne virus that can cause fever and joint pain, among other symptoms—scientists at the Stanford University School of Medicine have found a set of 20 genes that predicts who is at the highest risk of progressing to a severe form of the illness.

Every year, between 200 million and 400 million people in tropical and subtropical regions of the world contract dengue fever, and about 500,000 of those cases are fatal. For the most part, people with the disease recover after receiving some fluids and a few days’ rest, said Purvesh Khatri, Ph.D., associate professor of medicine and of biomedical data science. “But there’s a smaller subset of patients who get severe dengue, and right now we don’t know how to tell the difference.”

Anywhere from 5 to 20 percent of dengue cases will advance to severe. Currently, the standard of care boils down to watching and waiting: To diagnose severe dengue, doctors wait to observe specific symptoms and results of laboratory tests that typically emerge in the late stages of the disease. “These practices are not nearly sensitive or accurate enough, and some patients end up admitted to the hospital unnecessarily, while others are discharged prematurely,” said Shirit Einav, MD, associate professor of medicine and of microbiology and immunology.

Using their newly identified set of genes as a foundation, Einav and Khatri aim to identify predictive biomarkers that can help doctors reliably gauge the likelihood of severe dengue in patients who are newly symptomatic and use that information to provide more accurate care to help guide therapeutic clinical studies and, in the future, to guide treatment decisions.

A paper detailing the study’s findings will be published Jan. 29 in Cell Reports. Einav and Khatri are co-senior authors. Postdoctoral scholar Makeda Robinson, Ph.D., and former research associate Timothy Sweeny, MD, Ph.D., share lead authorship.

Mining old data

Adept at sleuthing out new findings from old data, Khatri used five previously published papers, which reported information on about 450 individuals collectively, to identify the severe-dengue gene set. Each study catalogued groups of dengue patients, tracking the “transcriptome,” or record of gene expression, at the onset of symptoms for each case.

“The papers had data on dengue patients from multiple countries. We looked at the data and asked, ‘Irrespective of the patient’s genetic background, age and the genetics of the dengue virus itself—different regions have different forms of dengue—what is the molecular response that always shows up when you have a dengue infection?'” Khatri said. “But we weren’t comparing healthy versus infected patients; we compared those who had an uncomplicated dengue infection with those who developed severe dengue.”

In analyzing data from the five studies, Khatri and Einav identified 20 genes that stood out. In all of the patients who developed severe dengue, these genes showed a specific expression pattern, or signature: Seventeen were underexpressed, whereas three were overactive. But predicting severe dengue is more complex than whether patients expressed this pattern; there’s variability. Some of the genes were down-regulated to a greater extent in some patients, and less so in others; likewise, there was variability in the degree of overactivity in the overexpressed genes.

“This prediction method is more of a continuum than a binary,” Khatri said. To make sense of the continuum, the researchers developed a score that accounted for this gene-expression variability, essentially evaluating the patients’ risk for severe dengue based on dips and piques of expression in these 20 genes. The higher the score, the higher the risk of severe dengue.

Then they tested their dengue-prediction method on data from three separate, previously published cohorts of dengue patients, whose transcriptome data was public, and found that the 20-gene set predicted 100 percent of the patients who developed severe dengue. Among those predicted to come down with severe dengue, 78 percent did.

Testing the test

Next, the researchers wanted to see if their predictive measure would succeed in a real-world patient population. So in partnership with the Clinical Research Center of the Valle del Lili Foundation, in Colombia, they set up a prospective cohort of 34 participants with dengue to assess the…

You maybe want to leaf through other part health over our linked article or you probably want to check it just as well-liked paper, I always posting this health article frequenlty for tips as well suggest as well gift that one may preserving our health as well as living this healthy lifestyle. This essay is updated by Linda Norton with this title Set Of Genes Predicts Severity Of Dengue, Study Reports.

Related posts of "Set of genes predicts severity of dengue, study reports"

Gene therapy cassettes improved for muscular dystrophy

A comparison of muscle samples from normal, untreated mice, mice with a muscular dystrophy disorder two years after receiving the new gene therapy, and untreated muscular dystrophy mice. Credit: Chamberlain Lab/UW Medicine Experimental gene therapy cassettes for Duchenne muscular dystrophy have been modified to deliver better performance. The cassettes, which carry the therapy into muscle...

Study reveals how blood cells help wounds heal scar-free

First author Christian F. Guerrero-Juarez (left) and Maksim Plikus, associate professor of developmental and cell biology. Credit: UCI New insights on circumventing a key obstacle on the road to anti-scarring treatment have been published by Maksim Plikus, an associate professor in development and cell biology at the UCI School of Biological Sciences and colleagues in...

HIV drug could treat Alzheimer’s, age-associated disorders

Lamivudine, a generic HIV/AIDS medication significantly reduces age-related inflammation in old mice by halting retrotransposon activity. Two weeks of treatment reduced the signs of chronic inflammation -- white blood cells stained pink amongst green fat cells -- in old mouse fat tissue. Credit: Sedivy Lab/Brown University A new study found that an HIV drug significantly...

A 9-year-old’s brain tumor left her paralyzed. After a Hopkins trial, doctors are using the word ‘cure.’

Eight years ago, Kaitlyn Dorman was so sick with cancer she was paralyzed and her vision blurred. Dependent on a wheelchair, the little girl was confined to living on the first floor of her family's home. Now 17, Kaitlyn can walk and see clearly. And she's staring down her final months at Liberty High School,...

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.